Lysosomal Diseases and Fibroblast Cultures: Biochemical and Electron Microscopic Observations

  • George Hug
  • William K. Schubert
  • Shirley Soukup
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 19)


Most lysosomal diseases are fatal, often after a protracted downhill course that is painfully apparent to patient, parents and physician. This interim report relates our attempts to treat such patients; and to find ultrastructural and biochemical markers in fibroblast cultures for the study of pathophysiology and treatment of lysosomal disease.


Gauche Disease Glycogen Storage Disease Fibroblast Culture Metachromatic Leukodystrophy Needle Biopsy Specimen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hug, G.: Non-bilirubin genetic disorders of the liver. International Academy of Pathology Monograph No. 13 “The Liver” ed. by E.A. Gall, The Williams and Wilkins Co. Baltimore, Md.; 1972.Google Scholar
  2. 2.
    Engel, A.G.: Acid maltase deficiency in adults: Studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain 93: 599, 1970.Google Scholar
  3. 3.
    Baudhuin, P., Hers, H.G., and Loeb, H.: An electron microscopic and biochemical study of Type II glycogenosis. Lab. Invest. 13: 1139, 1964.Google Scholar
  4. 4.
    Hers, H.G.: Alpha-glucosidase deficiency in generalized glycogen storage disease (Pompe’s disease). Biochem. J. 86: 11, 1963.Google Scholar
  5. 5.
    Hug, G., Garancis, J.C., Schubert, W.K., and Kaplan, S.: Glycogen storage disease, Types II, III, VIII, and IX. Amer. J. Dis. Child. 111: 457, 1966.Google Scholar
  6. 6.
    Hug, G. and Schubert, W.K.: Lysosomes in Type II glycogenosis. Changes during administration of extract from Aspergillus niger. J. Cell Biol. 35: C1, 1967.Google Scholar
  7. 7.
    Hug, G., Schubert, W.K., and Chuck, G.: Type II Glycogenosis: Treatment with extract of Aspergillus niger. Clin. Res. 16: 345, 1968.Google Scholar
  8. 8.
    Greene, H.L., Hug, G., and Schubert, W.K.: Metachromatic leukodystrophy: Treatment with arylsulfatase-A. Arch. Neurol. 20: 147, 1969.Google Scholar
  9. 9.
    Di Ferrante, N., Nichols, B.L., Donnelly, P.V., Neri, G., Hrgovcic, R. and Berglund, R.K.: Induced degradation of glycosaminoglycans in Hurler’s and Hunter’s syndromes by plasma infusion. Proc. Nat. Acad. Sci. U.S.A. 68: 303, 1971.Google Scholar
  10. 10.
    Porter, M.T., Fluharty, A.L., Kihara, H.: Metachromatic leukodystrophy: Arylsulfatase-A deficiency in skin fibroblast cultures. Proc. Nat. Acad. Sci. U.S.A. 62: 887, 1969.Google Scholar
  11. 11.
    Nitowsky, H.M. and Grumfeld, A.: Lysosomal alpha-glucosidase in Type II glycogenosis; activity in leucocytes and cell cultures in relation to genotype. J. Lab. Clin. Med. 69: 472, 1967.Google Scholar
  12. 12.
    Ho, M.W. and O’Brien, J.S.: Hurler’s syndrome: Deficiency of a specific beta galactosidase isoenzyme. Science 165: 611, 1969.Google Scholar
  13. 13.
    Fluharty, A.L., Porter, M.T., Lassila, E.L., Trammell, J., Carrel, R.E. and Kihara, H.: Acid glycosidases in mucopolysaccharidoses’ fibroblasts. Biochem. Med. 4: 110, 1970.Google Scholar
  14. 14.
    Hug, G., Schubert, W.K., and Soukup, S.: Ultrastructure and deficient arylsulfatase-A in fibroblast cultures of meta-chromatic leucodystrophy. J. Pediat. 76: 970, 1970.Google Scholar
  15. 15.
    Gregoire, A., Perier, 0., and Dustin, P. Jr.: Metachromatic Leukodystrophy: An electron microscopic study. J. Neuropath. Exp. Neurol. 25: 617, 1966.Google Scholar
  16. 16.
    Hug, G., Schubert, W.K., and Soukup, S.: Ultrastructure of fibroblast cultures, lymphocytes, and liver in mucopolysaccharidoses Types I, II, III, IV and VI. Proc. Electron Microscopy Society of America 28: 204, 1970.Google Scholar
  17. 17.
    Hug, G., Schubert, W.K., and Soukup, S.: Ultrastructure and enzymatic deficiency of fibroblast cultures in Type II glycogenosis. Pediat. Res. 5: 107, 1971.Google Scholar
  18. 18.
    Hug, G., Schubert, W.K., and Soukup, S.: Prenatal diagnosis of Type-II glycogenosis. Lancet 1: 1002, 1970.Google Scholar
  19. 19.
    Hug, G., Schubert, W.K., and Soukup, S.: Type II glycogenosis: Ultrastructure of amniotic fluid cells. In: Antenatal diagnosis, ed. by A. Dorfman, The University of Chicago Press, Chicago, Ill., 1972.Google Scholar
  20. 20.
    Hug, G., Schubert, W.K., and Soukup, S.: Electron microscopic demonstration of colloidal gold uptake into abnormal lysosomes of cultured fibroblasts from patients with Hurler’s syndrome and with Type II glycogenosis. Proc. Soc. Pediat. Res. 81: 5, 1971.Google Scholar
  21. 21.
    Okada, S., Veath, M.L., Leroy, J., and O’Brien, J.S.: Ganglioside GM2 storage diseases: Hexosaminidase deficiencies in cultured fibroblasts. Amer. J. Hum. Genet. 23: 55, 1971.Google Scholar

Copyright information

© Springer Science+Business Media New York 1972

Authors and Affiliations

  • George Hug
    • 1
  • William K. Schubert
    • 1
  • Shirley Soukup
    • 1
  1. 1.The Children’s Hospital Research FoundationUniversity of Cincinnati College of MedicineCincinnatiUSA

Personalised recommendations